Elevation Point Wealth Partners LLC purchased a new stake in shares of The Allstate Corporation (NYSE:ALL - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 22,019 shares of the insurance provider's stock, valued at approximately $5,259,000.
A number of other institutional investors also recently modified their holdings of the business. BlackRock Inc. purchased a new stake in shares of Allstate during the second quarter worth $5,439,448,000. State Street Corp boosted its position in shares of Allstate by 3.7% during the 4th quarter. State Street Corp now owns 12,297,551 shares of the insurance provider's stock valued at $2,571,600,000 after acquiring an additional 438,034 shares during the last quarter. Bank of America Corp DE increased its position in shares of Allstate by 8.1% in the first quarter. Bank of America Corp DE now owns 7,913,320 shares of the insurance provider's stock worth $1,640,748,000 after purchasing an additional 596,321 shares during the last quarter. GQG Partners LLC raised its stake in Allstate by 36.0% in the fourth quarter. GQG Partners LLC now owns 5,488,560 shares of the insurance provider's stock valued at $1,142,449,000 after purchasing an additional 1,452,993 shares in the last quarter. Finally, Franklin Resources Inc. lifted its position in Allstate by 29.2% during the fourth quarter. Franklin Resources Inc. now owns 5,007,549 shares of the insurance provider's stock valued at $1,042,321,000 after purchasing an additional 1,131,172 shares during the last quarter. 76.47% of the stock is currently owned by hedge funds and other institutional investors.
Allstate News Roundup
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
- Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
- Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
- Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
- Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
- Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates
Wall Street Analysts Forecast Growth
ALL has been the subject of a number of research reports. JPMorgan Chase & Co. boosted their price target on shares of Allstate from $282.00 to $292.00 and gave the stock an "overweight" rating in a research note on Tuesday, August 11th. HSBC cut shares of Allstate from a "buy" rating to a "hold" rating and raised their price objective for the company from $244.00 to $264.00 in a research report on Monday, July 6th. Keefe, Bruyette & Woods reiterated an "underperform" rating and issued a $250.00 target price (down from $255.00) on shares of Allstate in a research report on Thursday. Mizuho increased their target price on Allstate from $255.00 to $272.00 and gave the company an "outperform" rating in a research note on Thursday, July 9th. Finally, Wells Fargo & Company downgraded Allstate from an "equal weight" rating to an "underweight" rating and raised their price target for the company from $243.00 to $250.00 in a research report on Friday, August 7th. Four analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, eight have assigned a Hold rating and four have given a Sell rating to the stock. According to MarketBeat, Allstate presently has a consensus rating of "Hold" and an average price target of $265.26.
Get Our Latest Analysis on ALL
Allstate Trading Down 0.3%
ALL stock opened at $253.82 on Friday. The company has a market capitalization of $64.18 billion, a PE ratio of 5.07, a price-to-earnings-growth ratio of 0.39 and a beta of 0.16. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.36 and a current ratio of 0.36. The Allstate Corporation has a one year low of $188.08 and a one year high of $277.22. The company's 50 day moving average price is $250.34 and its two-hundred day moving average price is $224.95.
Allstate (NYSE:ALL - Get Free Report) last issued its earnings results on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, topping analysts' consensus estimates of $6.06 by $2.93. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The company had revenue of $18.60 billion for the quarter, compared to analysts' expectations of $15.46 billion. During the same quarter last year, the company earned $5.94 EPS. The firm's revenue was up 11.8% compared to the same quarter last year. As a group, analysts predict that The Allstate Corporation will post 34.45 earnings per share for the current fiscal year.
Allstate Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, August 31st will be paid a $1.08 dividend. This represents a $4.32 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Monday, August 31st. Allstate's payout ratio is presently 8.63%.
Insider Activity at Allstate
In other Allstate news, COO Mario Rizzo sold 56,225 shares of the business's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total value of $14,870,388.00. Following the transaction, the chief operating officer owned 82,227 shares in the company, valued at approximately $21,747,396.96. The trade was a 40.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Andrea Redmond sold 2,225 shares of the company's stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $202.91, for a total transaction of $451,474.75. Following the transaction, the director directly owned 2,225 shares of the company's stock, valued at approximately $451,474.75. This trade represents a 50.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 91,446 shares of company stock worth $24,208,675 in the last three months. 1.55% of the stock is owned by insiders.
Allstate Company Profile
(
Free Report)
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report